October 5-6 | Dallas

Available DatesRegister

Saturday October 05, 2024

  • 8:00 AM – 8:05 AM

    Welcome

    • Co-Chair
      • Corey LangerMD, FACP
      • Edward GaronMD, MS
  • 8:05 AM – 8:20 AM

    Debate: Handling Stage 3: Surgical vs. Non-Surgical Approach - Surgical Approach

    • Presenter
      • Kemp Kernstine, Sr.MD, PhD
  • 8:20 AM – 8:35 AM

    Debate: Handling Stage 3: Surgical vs. Non-Surgical Approach - Non-Surgical Approach

    • Presenter
      • Puneeth Iyengar
  • 8:35 AM – 8:45 AM

    Debate: Handling Stage 3: Surgical vs. Non-Surgical Approach - DISCUSSION

    • Panelist
      • Puneeth Iyengar
      • Kemp Kernstine, Sr.MD, PhD
  • 8:45 AM – 9:00 AM

    Debate: PD-L1 <1%: Is This the Place for CTLA-4 Inhibition in Lung Cancer? - YES

    • Presenter
      • Jason PorterMD
  • 9:00 AM – 9:15 AM

    Debate: PD-L1 <1%: Is This the Place for CTLA-4 Inhibition in Lung Cancer? - NO

    • Presenter
      • Natalie Vokes
  • 9:15 AM – 9:25 AM

    Debate: PD-L1 <1%: Is This the Place for CTLA-4 Inhibition in Lung Cancer? - DISCUSSION

    • Panelist
      • Jason PorterMD
      • Natalie Vokes
  • 9:25 AM – 9:35 AM

    Break

  • 9:35 AM – 10:35 AM

    Non-CME Innovation Theater - Sponsored by Catalyst

  • 10:35 AM – 11:15 AM

    Recognizing and Managing Lambert-Eaton Myasthenic Syndrome Associated with Small Cell Lung Cancer

    • Presenter
      • Jennifer CarlisleMD

Agenda coming soon!

The agenda features a mix of clinical updates and lively debates on provocative scientific topics in the field.